Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Detalles Bibliográficos
Autores principales: Sommerstein, Rami, Kochen, Michael M., Messerli, Franz H., Gräni, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428596/
https://www.ncbi.nlm.nih.gov/pubmed/32233753
http://dx.doi.org/10.1161/JAHA.120.016509
_version_ 1783571109869780992
author Sommerstein, Rami
Kochen, Michael M.
Messerli, Franz H.
Gräni, Christoph
author_facet Sommerstein, Rami
Kochen, Michael M.
Messerli, Franz H.
Gräni, Christoph
author_sort Sommerstein, Rami
collection PubMed
description
format Online
Article
Text
id pubmed-7428596
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74285962020-08-17 Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Sommerstein, Rami Kochen, Michael M. Messerli, Franz H. Gräni, Christoph J Am Heart Assoc Viewpoints John Wiley and Sons Inc. 2020-04-01 /pmc/articles/PMC7428596/ /pubmed/32233753 http://dx.doi.org/10.1161/JAHA.120.016509 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Viewpoints
Sommerstein, Rami
Kochen, Michael M.
Messerli, Franz H.
Gräni, Christoph
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title_full Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title_fullStr Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title_full_unstemmed Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title_short Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
title_sort coronavirus disease 2019 (covid‐19): do angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428596/
https://www.ncbi.nlm.nih.gov/pubmed/32233753
http://dx.doi.org/10.1161/JAHA.120.016509
work_keys_str_mv AT sommersteinrami coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect
AT kochenmichaelm coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect
AT messerlifranzh coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect
AT granichristoph coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect

Ejemplares similares